Fig. 5From: GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphomaGM-CSF induces disease progression in ENKTL. a The PFS and OS of ENKTL patients who have received GM-CSF treatment compared to ENKTL patients who have not received GM-CSF treatment. b Imaging data of a patient who had disease progression after treated by GM-CSF. The patient has received good partial remission after chemotherapy and was treated by GM-CSF for hematopoietic stem cell mobilization, who relapsed within 1 month. c Test results of serum EBV-DNA of five ENKTL patients who have been treated by GM-CSF. Patients who were treated by GM-CSF could induce elevated serum EBV-DNA copies, which could be reduced after chemotherapyBack to article page